Predicting Plasmodium falciparum kinase inhibitors from antimalarial medicinal herbs using computational modeling approach
Abstract Malaria remains a significant public health challenge, with resistance to available drugs necessitating the development of novel therapies targeting invasion-dependent proteins. Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK-1) is essential for host erythrocyte invasion and parasite asexual development. This study screened a library of 490 compounds using computational methods to identify potential PfCDPK-1 inhibitors. Three compounds; 17-hydroxyazadiradione, Picracin, and Epicatechin-gallate derived from known antimalarial botanicals, showed potent inhibitory effects on PfCDPK-1. These compounds exhibited better binding affinities (−8.8, −9.1, −9.3 kCal/mol respectively), pharmacokinetics, and physicochemical properties than the purported inhibitory standard of PfCDPK-1, Purfalcamine. Molecular dynamics simulations (50 ns) and molecular mechanics analyses confirmed the stability and binding rigidity of these compounds at the active pocket of PfCDPK-1. The results suggest that these compounds are promising pharmacological targets with potential therapeutic effects for malaria treatment/management without undesirable side effects. Therefore, this study provides new insights into the development of effective antimalarial agents targeting invasion-dependent proteins, which could help combat the global malaria burden..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
In Silico Pharmacology - 12(2023), 1 vom: 19. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Adelusi, Temitope Isaac [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
CDPK1 |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s40203-023-00175-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR05413787X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR05413787X | ||
| 003 | DE-627 | ||
| 005 | 20231220064637.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231220s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40203-023-00175-z |2 doi | |
| 035 | |a (DE-627)SPR05413787X | ||
| 035 | |a (SPR)s40203-023-00175-z-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Adelusi, Temitope Isaac |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Predicting Plasmodium falciparum kinase inhibitors from antimalarial medicinal herbs using computational modeling approach |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract Malaria remains a significant public health challenge, with resistance to available drugs necessitating the development of novel therapies targeting invasion-dependent proteins. Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK-1) is essential for host erythrocyte invasion and parasite asexual development. This study screened a library of 490 compounds using computational methods to identify potential PfCDPK-1 inhibitors. Three compounds; 17-hydroxyazadiradione, Picracin, and Epicatechin-gallate derived from known antimalarial botanicals, showed potent inhibitory effects on PfCDPK-1. These compounds exhibited better binding affinities (−8.8, −9.1, −9.3 kCal/mol respectively), pharmacokinetics, and physicochemical properties than the purported inhibitory standard of PfCDPK-1, Purfalcamine. Molecular dynamics simulations (50 ns) and molecular mechanics analyses confirmed the stability and binding rigidity of these compounds at the active pocket of PfCDPK-1. The results suggest that these compounds are promising pharmacological targets with potential therapeutic effects for malaria treatment/management without undesirable side effects. Therefore, this study provides new insights into the development of effective antimalarial agents targeting invasion-dependent proteins, which could help combat the global malaria burden. | ||
| 650 | 4 | |a CDPK1 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Malaria |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Molecular docking |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Molecular simulation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Virtual screening |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Ojo, Taiwo Ooreoluwa |4 aut | |
| 700 | 1 | |a Bolaji, Olawale Quadri |4 aut | |
| 700 | 1 | |a Oyewole, Moyosoluwa Precious |4 aut | |
| 700 | 1 | |a Olaoba, Olamide Tosin |4 aut | |
| 700 | 1 | |a Oladipo, Elijah Kolawole |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t In Silico Pharmacology |d Berlin : SpringerOpen, 2013 |g 12(2023), 1 vom: 19. Dez. |w (DE-627)SPR032902050 |w (DE-600)2702993-1 |x 2193-9616 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:1 |g day:19 |g month:12 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s40203-023-00175-z |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 1 |b 19 |c 12 | ||